← Scroll for more →
Financial Statements — RMSGW
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.85 | 0.85 | 2.58 | -- | 0.60 | -- | -- |
| Total Current Assets | 1.08 | 1.08 | 3.79 | -- | 1.62 | -- | -- |
| Property, Plant & Equipment | 0.08 | 0.08 | 0.03 | -- | 0.05 | -- | -- |
| Total Non-current Assets | 0.27 | 0.27 | 0.26 | -- | 0.05 | -- | -- |
| Total Assets | 1.34 | 1.34 | 4.05 | -- | 1.67 | -- | -- |
| Total Current Liabilities | 0.12 | 0.12 | 0.19 | -- | 0.30 | -- | -- |
| Total Non-current Liabilities* | 0.12 | 0.12 | 0.16 | -- | 5.02 | -- | -- |
| Total Liabilities | 0.23 | 0.23 | 0.35 | -- | 5.32 | -- | -- |
| Retained Earnings | (22.51) | (22.51) | (20.12) | -- | (16.75) | -- | -- |
| Total Stockholder Equity | 1.11 | 1.11 | 3.70 | (5.32) | (3.66) | 1.24 | (7.43) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 |
|---|---|
| Total Revenue | 0.03 |
| Cost of Revenue | 0.01 |
| Gross Profit | 0.01 |
| Research & Development | 0.29 |
| Selling, General & Admin | 1.96 |
| Total Operating Expenses | 2.42 |
| Operating Income | (2.40) |
| Pretax Income | (2.38) |
| Net Income | (2.38) |
| Basic EPS | (0.25) |
| Diluted EPS | (0.25) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 |
|---|---|
| Operating Cash Flow | (1.56) |
| Capital Expenditures | 0.01 |
| Free Cash Flow* | (1.56) |
| Investing Cash Flow | (0.16) |
| Financing Cash Flow | 7.08 |
← Scroll for more columns →
* Derived from reported values